122 related articles for article (PubMed ID: 32065087)
1. Docking Related Survey on Heterocyclic Compounds Based on Glucosamine-6- Phosphate Synthase Inhibitors and their Antimicrobial Potential.
Lather A; Sharma S; Khatkar S; Khatkar A
Curr Pharm Des; 2020; 26(15):1650-1665. PubMed ID: 32065087
[TBL] [Abstract][Full Text] [Related]
2. Virtual Screening of Novel Glucosamine-6-Phosphate Synthase Inhibitors.
Lather A; Sharma S; Khatkar A
Comb Chem High Throughput Screen; 2018; 21(3):182-193. PubMed ID: 29600755
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of glucosamine-6-phosphate synthase as potential antimicrobials or antidiabetics - synthesis and properties.
Stefaniak J; Nowak MG; Wojciechowski M; Milewski S; Skwarecki AS
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1928-1956. PubMed ID: 35801410
[TBL] [Abstract][Full Text] [Related]
4. Molecular docking studies of fused coumarin derivatives as inhibitors of GlcN-6.
Govori S; Haziri A; Ademi K; Neziraj N
J Environ Sci Health A Tox Hazard Subst Environ Eng; 2017 Sep; 52(11):1041-1045. PubMed ID: 28737449
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antimicrobial activity of 6-sulfo-6-deoxy-D-glucosamine and its derivatives.
Skarbek K; Gabriel I; Szweda P; Wojciechowski M; Khan MA; Görke B; Milewski S; Milewska MJ
Carbohydr Res; 2017 Aug; 448():79-87. PubMed ID: 28628891
[TBL] [Abstract][Full Text] [Related]
6. Glucosamine-6-phosphate synthase, a novel target for antifungal agents. Molecular modelling studies in drug design.
Wojciechowski M; Milewski S; Mazerski J; Borowski E
Acta Biochim Pol; 2005; 52(3):647-53. PubMed ID: 16082410
[TBL] [Abstract][Full Text] [Related]
7. Glucosamine-6-phosphate synthase inhibiting C3-β-cholesterol tethered spiro heterocyclic conjugates: Synthesis and their insight of DFT and docking study.
Periyasami G; Kamalraj S; Padmanaban R; Yeswanth Kumar S; Stalin A; Arumugam N; Suresh Kumar R; Rahaman M; Durairaju P; Alrehaili A; Aldalbahi A
Bioorg Chem; 2019 Jul; 88():102920. PubMed ID: 30991194
[TBL] [Abstract][Full Text] [Related]
8. Naringin derivatives as glucosamine-6-phosphate synthase inhibitors based preservatives and their biological evaluation.
Lather A; Sharma S; Khatkar A
Sci Rep; 2020 Nov; 10(1):20477. PubMed ID: 33235242
[TBL] [Abstract][Full Text] [Related]
9. Naringenin derivatives as glucosamine-6-phosphate synthase inhibitors: synthesis, antioxidants, antimicrobial, preservative efficacy, molecular docking and in silico ADMET analysis.
Lather A; Sharma S; Khatkar A
BMC Chem; 2020 Dec; 14(1):41. PubMed ID: 32577624
[TBL] [Abstract][Full Text] [Related]
10. Long range molecular dynamics study of interactions of the eukaryotic glucosamine-6-phosphate synthase with fructose-6-phosphate and UDP-GlcNAc.
Miszkiel A; Wojciechowski M
J Mol Graph Model; 2017 Nov; 78():14-25. PubMed ID: 28968565
[TBL] [Abstract][Full Text] [Related]
11. Engineering Glucosamine-6-Phosphate Synthase to Achieve Efficient One-Step Biosynthesis of Glucosamine.
Guan ZB; Deng XT; Zhang ZH; Xu GC; Cheng WL; Liao XR; Cai YJ
ACS Chem Biol; 2024 Jun; 19(6):1237-1242. PubMed ID: 38723147
[TBL] [Abstract][Full Text] [Related]
12. Aesculin based glucosamine-6-phosphate synthase inhibitors as novel preservatives for food and pharmaceutical products: in-silico studies, antioxidant, antimicrobial and preservative efficacy evaluation.
Lather A; Sharma S; Khatkar A
BMC Chem; 2021 Jul; 15(1):45. PubMed ID: 34315523
[TBL] [Abstract][Full Text] [Related]
13. Mapping the UDP-N-acetylglucosamine regulatory site of human glucosamine-6P synthase by saturation-transfer difference NMR and site-directed mutagenesis.
Assrir N; Richez C; Durand P; Guittet E; Badet B; Lescop E; Badet-Denisot MA
Biochimie; 2014 Feb; 97():39-48. PubMed ID: 24075873
[TBL] [Abstract][Full Text] [Related]
14. In silico approach towards polyphenols as targeting glucosamine-6-phosphate synthase for
Dhawale S; Pandit M; Thete K; Ighe D; Gawale S; Bhosle P; Lokwani DK
J Biomol Struct Dyn; 2023; 41(21):12038-12054. PubMed ID: 36629053
[No Abstract] [Full Text] [Related]
15. Synthesis, HIV-1 RT inhibitory, antibacterial, antifungal and binding mode studies of some novel N-substituted 5-benzylidine-2,4-thiazolidinediones.
Bahare RS; Ganguly S; Choowongkomon K; Seetaha S
Daru; 2015 Jan; 23(1):6. PubMed ID: 25617150
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activity of novel ester derivatives of N(3)-(4-metoxyfumaroyl)-(S)-2,3-diaminopropanoic acid containing amide and keto function as inhibitors of glucosamine-6-phosphate synthase.
Pawlak D; Schielmann M; Wojciechowski M; Andruszkiewicz R
Bioorg Med Chem Lett; 2016 Aug; 26(15):3586-9. PubMed ID: 27324977
[TBL] [Abstract][Full Text] [Related]
17. Amygdalin based G-6-P synthase inhibitors as novel preservatives for food and pharmaceutical products.
Lather A; Sharma S; Khatkar A
Sci Rep; 2020 Aug; 10(1):13903. PubMed ID: 32807915
[TBL] [Abstract][Full Text] [Related]
18. N3-haloacetyl derivatives of L-2,3-diaminopropanoic acid: novel inactivators of glucosamine-6-phosphate synthase.
Milewski S; Chmara H; Andruszkiewicz R; Borowski E
Biochim Biophys Acta; 1992 Jan; 1115(3):225-9. PubMed ID: 1739736
[TBL] [Abstract][Full Text] [Related]
19. Amide and ester derivatives of N3-trans-epoxysuccinoyl-L-2,3-diaminopropanoic acid: inhibitors of glucosamine-6-phosphate synthase.
Andruszkiewicz R; Milewski S; Borowski E
J Enzyme Inhib; 1995; 9(2):123-33. PubMed ID: 8583250
[TBL] [Abstract][Full Text] [Related]
20. Glutamine analogues containing a keto function--novel inhibitors of fungal glucosamine-6-phosphate synthase.
Walkowiak A; Wakieć R; Bontemps-Gracz MM; Andruszkiewicz R
J Enzyme Inhib Med Chem; 2005 Oct; 20(5):439-47. PubMed ID: 16335051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
